Showing 44,661 - 44,680 results of 74,164 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (we decrease)) ))', query time: 0.96s Refine Results
  1. 44661
  2. 44662
  3. 44663
  4. 44664
  5. 44665
  6. 44666
  7. 44667
  8. 44668
  9. 44669

    Table_2_Dose-dependent effects of GAT107, a novel allosteric agonist-positive allosteric modulator (ago-PAM) for the α7 nicotinic cholinergic receptor: a BOLD phMRI and connectivit... by Brittany M. Brems (13174467)

    Published 2023
    “…The hippocampus, hypothalamus, amygdala, brainstem, and cerebellum showed little activation. Forty-five min post treatment with GAT107, data for resting state functional connectivity were acquired and showed a global decrease in connectivity as compared to vehicle.…”
  10. 44670

    Image_1_Dose-dependent effects of GAT107, a novel allosteric agonist-positive allosteric modulator (ago-PAM) for the α7 nicotinic cholinergic receptor: a BOLD phMRI and connectivit... by Brittany M. Brems (13174467)

    Published 2023
    “…The hippocampus, hypothalamus, amygdala, brainstem, and cerebellum showed little activation. Forty-five min post treatment with GAT107, data for resting state functional connectivity were acquired and showed a global decrease in connectivity as compared to vehicle.…”
  11. 44671

    Table_1_Dose-dependent effects of GAT107, a novel allosteric agonist-positive allosteric modulator (ago-PAM) for the α7 nicotinic cholinergic receptor: a BOLD phMRI and connectivit... by Brittany M. Brems (13174467)

    Published 2023
    “…The hippocampus, hypothalamus, amygdala, brainstem, and cerebellum showed little activation. Forty-five min post treatment with GAT107, data for resting state functional connectivity were acquired and showed a global decrease in connectivity as compared to vehicle.…”
  12. 44672

    Data Sheet 1_Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma.docx by Abraham Alí-Munive (21347201)

    Published 2025
    “…FEV<sub>1</sub>pp showed higher but not significant values from the 2–4-month period, with a median change of 12.5% (IQR: 0.3, 21.5). The proportion of patients with uncontrolled asthma (ACT ≤15) decreased from 68% at baseline to 19% and 20% at year-one and second year of treatment, respectively (p = 0.003). …”
  13. 44673

    DataSheet4_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.pdf by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  14. 44674

    DataSheet2_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.docx by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  15. 44675

    DataSheet2_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.docx by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  16. 44676

    DataSheet4_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.pdf by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  17. 44677

    DataSheet3_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.pdf by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  18. 44678

    DataSheet1_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.docx by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  19. 44679

    DataSheet3_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.pdf by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”
  20. 44680

    DataSheet1_Shuxuening injection for treating acute ischemic stroke: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.docx by Jie Zhan (842099)

    Published 2024
    “…SXNI plus CTs also decreased the Chinese Stroke Scale score compared with CTs alone (MD: </p><p>−5.01, 95% CI: −7.38 to −2.65, p < 0.0001) or CTs plus other injections (MD: −4.31, 95% CI: −5.75 to −2.88, p < 0.0001). …”